The current price of EW is $101.56 — it has increased by 0.73% since the previous close. Data as of Nov 6, 2026.
EW is up 7.41% over the past week, up 17.44% over the past month and up 23.19% over the past year. The price is above its 200-day moving average of $85.68.
Analysts' average 12-month price target for EW is $108.70, which implies 7.03% upside from the current price. Individual estimates range from $100.00 to $120.00.
Of the 31 analysts covering Edwards Lifesciences Corporation, 5 rate it a strong buy, 19 rate it a buy and 7 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Edwards Lifesciences Corporation has a market capitalization of $58.54B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Edwards Lifesciences Corporation posted earnings of $0.80 per share against an estimate of $0.744, beating expectations by 7.53%. Upcoming reports are listed in the earnings calendar.
Edwards Lifesciences Corporation reported revenue of $1.72B in its most recent quarter, which has increased by 10.46% compared with the same quarter a year earlier. Analysts had expected $1.68B.
Edwards Lifesciences Corporation has not paid any dividends over the past year.
Companies most comparable to Edwards Lifesciences Corporation include Intuitive Surgical, Inc., APT Medical Inc., Siemens Healthineers AG, Terumo Corporation and Olympus Corporation.
In the latest trading session EW moved between $98.50 and $101.64, a range of 3.09% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Edwards Lifesciences Corporation shows a strong buy rating today and a strong buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks EW has traded between $74.66 and $104.17. The current price is 2.51% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.